Ratings for Praxis Precision Medicine (NASDAQ:PRAX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 1 | 0 | 0 | 0 |
| 2M Ago | 2 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Praxis Precision Medicine, presenting an average target of $116.43, a high estimate of $150.00, and a low estimate of $105.00. This current average has increased by 3.49% from the previous average price target of $112.50.
Decoding Analyst Ratings: A Detailed Look
A comprehensive examination of how financial experts perceive Praxis Precision Medicine is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Joon Lee | Truist Securities | Maintains | Buy | $150.00 | $150.00 |
| Douglas Tsao | HC Wainwright & Co. | Maintains | Buy | $105.00 | – |
| Joel Beatty | Baird | Announces | Outperform | $117.00 | – |
| Douglas Tsao | HC Wainwright & Co. | Maintains | Buy | $105.00 | – |
| Kambiz Yazdi | Jefferies | Raises | Buy | $128.00 | $75.00 |
| Douglas Tsao | HC Wainwright & Co. | Maintains | Buy | $105.00 | – |
| Douglas Tsao | HC Wainwright & Co. | Maintains | Buy | $105.00 | – |
Key Insights:
Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ their stance, it reflects their reaction to recent developments related to Praxis Precision Medicine. This information provides a snapshot of how analysts perceive the current state of the company.
Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from ‘Outperform’ to ‘Underperform’. These ratings convey expectations for the relative performance of Praxis Precision Medicine compared to the broader market.
Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Praxis Precision Medicine’s stock. This comparison…
Click Here to Read the Full Original Article at Cryptocurrencies Feed…
